🔗 Share this article

Texas Attorney General Ken Paxton is suing the makers of acetaminophen, asserting the firms withheld alleged dangers that the drug created to children's neurological development.

This legal action arrives a month after Donald Trump publicized an unproven link between using Tylenol - referred to as paracetamol - during pregnancy and autism in young ones.

The attorney general is taking legal action against Johnson & Johnson, which previously sold the drug, the only pain reliever approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a official comment, he said they "misled consumers by gaining financially from discomfort and promoting medication without regard for the dangers."

The company says there is lacking scientific proof tying Tylenol to autism spectrum disorder.

"These corporations deceived for years, knowingly endangering countless individuals to boost earnings," Paxton, a Republican, declared.

Kenvue commented that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its online platform, Kenvue also stated it had "regularly reviewed the pertinent research and there is lacking reliable evidence that demonstrates a proven link between using acetaminophen and autism spectrum disorder."

Groups speaking for doctors and healthcare providers share this view.

The leading OB-GYN organization has said paracetamol - the key substance in Tylenol - is a restricted selection for expectant mothers to manage pain and elevated temperature, which can present major wellness concerns if ignored.

"In over twenty years of research on the consumption of paracetamol in gestation, not a single reputable study has definitively established that the use of acetaminophen in any stage of pregnancy results in brain development issues in young ones," the organization stated.

The court filing references current declarations from the previous government in arguing the medication is allegedly unsafe.

In recent weeks, the former president caused concern from health experts when he instructed pregnant women to "resist strongly" not to take Tylenol when ill.

The US Food and Drug Administration then released a statement that doctors should think about restricting the usage of Tylenol, while also declaring that "a direct connection" between the medication and autism in minors has not been established.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had pledged in spring to undertake "a massive testing and research effort" that would determine the origin of autism in a limited time.

But specialists advised that discovering a unique factor of autism - believed by scientists to be the outcome of a intricate combination of inherited and environmental factors - would be difficult.

Autism is a type of permanent neurological difference and condition that influences how persons experience and interact with the environment, and is diagnosed using medical professional evaluations.

In his lawsuit, the attorney general - aligned with the former president who is campaigning for US Senate - claims Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

The case attempts to require the companies "destroy any marketing or advertising" that states acetaminophen is safe for pregnant women.

The Texas lawsuit mirrors the complaints of a collection of guardians of minors with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in two years ago.

The court threw out the lawsuit, declaring investigations from the plaintiffs' authorities was lacking definitive proof.